Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Reasoning Training in Individuals With Bipolar Disorder [NA]
A completed clinical trial from The University of Texas at Dallas examined reasoning training in individuals with bipolar disorder, with res…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Focused Ultrasound Amygdala Neuromodulation [NA]
This entry reports an ongoing clinical trial using focused ultrasound to modulate the amygdala for depression and anxiety-related disorders;…
-
FDA approval · 2024-12-05FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for divalproex sodium submitted by Unichem Pharmaceuticals (USA), Inc. under ANDA079163. This ac…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders
A completed translational clinical trial investigating dysbindin-associated pharmacogenetics to tailor antipsychotic treatment for bipolar d…
-
FDA approval · 2024-12-03FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for lurasidone hydrochloride from Amneal Pharmaceuticals LLC, supporting the generic product's conti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-26FDA Approved: OLANZAPINE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Ascend Laboratories, LLC to market a generic olanzapine product under an ANDA. This marks the cl…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach [NA]
This study investigates the behavioral variant frontotemporal dementia and bipolar disorder using neuroimaging and epigenetics. The trial is…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Effects of Lurasidone on Left Ventricle Systolic Functions
A clinical trial is evaluating how lurasidone affects left ventricular systolic function in patients with schizophrenia or bipolar disorder;…
-
FDA approval · 2024-11-18FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Quetiapine fumarate by Macleods Pharmaceuticals Limited, enabling a generic version of the a…
-
FDA approval · 2024-11-18FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved chlorpromazine hydrochloride as a generic product under an original ANDA for Camber Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Synaptic Imaging and Network Activity in Treatment Resistant Depression [NA]
King's College London completed a clinical trial investigating synaptic imaging and network activity in treatment-resistant depression.
-
FDA approval · 2024-11-12FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic form of aripiprazole from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Efficacy of Convulsive Therapies During Continuation [NA]
Completed study evaluating the efficacy of convulsive therapies during the continuation phase for depression, including unipolar, bipolar, a…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Efficacy of Convulsive Therapies for Bipolar Depression [NA]
A completed clinical trial evaluating the efficacy of convulsive therapies for bipolar depression, sponsored by the Centre for Addiction and…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth [NA]
This ClinicalTrials.gov update describes an ongoing study evaluating Narrative Enhancement and Cognitive Therapy for self-stigma in youth wi…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment [Phase 4]
Phase 4 trial comparing remimazolam and etomidate as induction agents for electroconvulsive therapy has completed, potentially informing ane…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Lithium for Prevention of Cognitive Declining in Mood Illnesses [Phase 4]
Phase 4 clinical trial update on lithium for prevention of cognitive decline in mood disorders, with current status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression
A completed clinical trial investigates cognitive effects associated with hippocampal neurogenesis induced by electroconvulsive therapy in t…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients [Phase 3]
A Phase 3 trial evaluating cariprazine for cognitive impairment in euthymic Bipolar I Disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Voice Changes During ECT
This update summarizes a completed clinical trial evaluating voice changes during electroconvulsive therapy (ECT) for depressive disorders. …
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: A Study on the Preference of Risperidone Dosage Forms
Clinical trial sponsored by Shanghai Mental Health Center evaluating preferences for risperidone dosage forms across schizophrenia, bipolar …
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Mood Disorders in Multiple Sclerosis Patients
This clinical trial update confirms that a study evaluating mood disorders in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses [NA]
The clinical trial 'Opening Doors to Recovery' for persons with serious mental illnesses has completed and posted results, sponsored by the …
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients [Phase 1, Phase 2]
This completed Phase 1/2 trial examined whether sleep deprivation enhances the antidepressant effects of sertraline via dopamine metabolism …
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
The document notes the completion of a clinical trial evaluating quetiapine extended-release tablets for depressive symptoms in patients wit…